Search results for " Diagnostics"

showing 10 items of 170 documents

Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders

2020

Contains fulltext : 218274.pdf (Publisher’s version ) (Closed access) Genetic syndromes frequently present with overlapping clinical features and inconclusive or ambiguous genetic findings which can confound accurate diagnosis and clinical management. An expanding number of genetic syndromes have been shown to have unique genomic DNA methylation patterns (called "episignatures"). Peripheral blood episignatures can be used for diagnostic testing as well as for the interpretation of ambiguous genetic test results. We present here an approach to episignature mapping in 42 genetic syndromes, which has allowed the identification of 34 robust disease-specific episignatures. We examine emerging pa…

0301 basic medicine[SDV]Life Sciences [q-bio]Computational biology030105 genetics & heredityBiologyPediatricsArticleCohort Studiesmolecular diagnostics03 medical and health sciencessymbols.namesakeGenetic HeterogeneityGene duplicationGeneticsHumansHunter-McAlpine syndromeGenetics (clinical)Mass screening030304 developmental biologyEpiSignGenetics0303 health sciencesNeurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7]DNA methylationGenetic heterogeneity030305 genetics & heredityCorrectionSyndromeDNA MethylationMolecular diagnosticsPhenotypePenetranceHuman genetics3. Good healthepisignaturegenomic DNA030104 developmental biologyPhenotypeNeurodevelopmental DisordersDNA methylationuncertain clinical casesMendelian inheritancesymbolsIdentification (biology)VUS classification
researchProduct

Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH sur…

2017

Background Scant information is available about how transplant centers are managing their use of quantitative molecular testing (QNAT) assays for active cytomegalovirus (CMV) infection monitoring in solid organ transplant (SOT) recipients. The current study was aimed at gathering information on current practices in the management of CMV infection across European centers in the era of molecular testing assays. Methods A questionnaire-based cross-sectional survey study was conducted by the European Study Group of Infections in Immunocompromised Hosts (ESGICH) of the Society of Clinical Microbiology and Infectious Diseases (ESCMID). The invitation and a weekly reminder with a personal link to …

0301 basic medicinecytomegalovirus; solid organ transplantation; survey.cytomegalovirus ; solid organ transplantation ; surveyCross-sectional studyCytomegalovirusTransplantsPractice Patterns030230 surgeryOrgan transplantationlaw.invention0302 clinical medicinePostoperative Complicationslaw03.02. Klinikai orvostanViralPractice Patterns Physicians'solid organ transplantationPolymerase chain reactionViral LoadEuropeInfectious DiseasesCytomegalovirus InfectionsPractice Guidelines as Topiccytomegalovirus; solid organ transplantation; survey; Antibiotic Prophylaxis; Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus; Cytomegalovirus Infections; DNA Viral; Europe; Guideline Adherence; Health Care Surveys; Humans; Immunocompromised Host; Immunosuppression; Organ Transplantation; Postoperative Complications; Practice Guidelines as Topic; Practice Patterns Physicians'; Real-Time Polymerase Chain Reaction; Transplant Recipients; Transplants; Viral LoadGuideline Adherencecytomegalovirus; solid organ transplantation; survey; Antibiotic Prophylaxis; Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus; Cytomegalovirus Infections; DNA Viral; Europe; Guideline Adherence; Health Care Surveys; Humans; Immunocompromised Host; Immunosuppression; Organ Transplantation; Postoperative Complications; Practice Guidelines as Topic; Practice Patterns Physicians'; Real-Time Polymerase Chain Reaction; Transplant Recipients; Transplants; Viral Load; Transplantation; Infectious Diseasesmedicine.medical_specialty030106 microbiologyCongenital cytomegalovirus infectionReal-Time Polymerase Chain ReactionAntiviral Agents03 medical and health sciencesImmunocompromised HostmedicineHumanssurveyIntensive care medicineImmunosuppression TherapyTransplantationPhysicians'business.industryDNAOrgan TransplantationAntibiotic Prophylaxismedicine.diseaseMolecular diagnosticsTransplant RecipientsCytomegalovirus infectionTransplantationcytomegalovirus; solid organ transplantation; survey; Transplantation; Infectious DiseasesCross-Sectional StudiesCytomegalovirus; Solid organ transplantation; Survey; Transplantation; Infectious DiseasesHealth Care SurveysDNA ViralImmunologySolid organ transplantationbusinessImmunosuppression
researchProduct

Separase is a marker for prognosis and mitotic activity in breast cancer

2017

Background: Cancer cell proliferation is a critical feature in classifying and predicting the outcome of breast carcinoma. Separase has a central role in cell cycle progression in unleashing sister-chromatids at anaphase onset. Abnormally functioning separase is known to lead to chromosomal instability. Methods: The study comprises 349 breast carcinoma patients treated in Central Hospital of Central Finland. The prognostic value, role as a proliferation marker and regulatory interactions of separase are evaluated by immunohistochemical and double- and triple-immunofluorescence (IF) detections based on complete clinical data and >22-year follow-up of the patient material. Results: In our mat…

0301 basic medicineentsyymitCancer Researchcyclin B1proliferationenzymesMitosismarkersBreast NeoplasmsBiologyta311103 medical and health sciencesbreast cancerBreast cancerseparaseBiomarkers TumormedicineHumansProliferation MarkerCyclin B1Molecular DiagnosticsSurvival rateNeoplasm StagingAnaphaseGeneticsrintasyöpäsecurinPrognosista3122medicine.diseaseSurvival Rate030104 developmental biologyOncologySecurinmarkkeritCancer researchFemaleSeparaseBreast carcinomaESPL1British Journal of Cancer
researchProduct

Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care

2021

Early detection is the first step in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, an efficient, rapid, selective, specific, and inexpensive SARS-CoV-2 diagnostic method is the need of the hour. The reverse transcription-polymerase chain reaction (RT-PCR) technology is massively utilized to detect infection with SARS-CoV-2. However, scientists continue to strive to create enhanced technology while continually developing nanomaterial-enabled biosensing methods that can provide new methodologies, potentially fulfilling the present demand for rapid and early identification of coronavirus disease 2019 (COVID-19) patients. Our review presents a summar…

2019-20 coronavirus outbreakmedicine.medical_specialtyDiagnostic methodsMaterials scienceCoronavirus disease 2019 (COVID-19)SARS-CoV-2virusesMechanical EngineeringSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)fungiEarly detectionCondensed Matter PhysicsArticlePolymerase chain reactionBiosensors02 Physical Sciences 03 Chemical Sciences 09 EngineeringMechanics of MaterialsmedicineGeneral Materials ScienceCOVID-19 clinical diagnosticsSevere acute respiratory syndrome coronavirusIntensive care medicineMaterialsNanomaterialsPoint of careMaterials Letters
researchProduct

3-4 gadīgu bērnu pirmreizēja agrīna diagnosticēšana vispārējā pirmsskolas izglītības iestādē

2017

Autore diplomdarba tēmu „3 - 4 gadīgu bērnu pirmreizēja agrīna diagnosticēšana vispārējā pirmsskolas izglītības iestādē” izvēlējusies, jo strādā Rīgas pirmsskolas izglītības iestādē par skolotāju logopēdi un gan viņa, gan viņas kolēģi darbā sastopas ar gadījumiem, kad bērnam nepieciešamāka agrīnāka diagnosticēšana nekā tas paredzēts pašreiz. Pirmsskolas izglītības iestādē ir viens dokuments – valodas karte, pēc kuras tiek veikta pirmreizēja diagnostika 5 – 7 gadīgiem bērniem no vecākās un sagatavošanas grupas, tādēļ autorei šķita svarīgi izveidot materiālu – darba lapu, pēc kuras varētu veikt pirmreizējo agrīno diagnostiku 3 – 4 gadus veciem bērniem. Darbā no teorētiskā viedokļa ir aplūkota…

3 – 4 years old childrenagrīna diagnosticēšana3 – 4 gadīgie bērnivispārēja pirmsskolas izglītības iestādePedagoģijaearly diagnostics
researchProduct

On the Detection of Distributed Roughness on Ball Bearings Via Stator Current Energy: Experimental Results

2009

ANOVADistributed roughness ball bearing stator currentdistributed roughnessbearing diagnostics; distributed roughness; ANOVA; GLM; induction motorGLMbearing diagnostics distributed roughness ANOVA GLM induction motorbearing diagnosticsinduction motor
researchProduct

Salivary MMP-9 in the detection of oral squamous cell carcinoma

2017

Background Oral squamous cell carcinoma (OSCC) is the most common malignant tumour of the oral cavity. Detection of OSCC is currently based on clinical oral examination combined with histopathological evaluation of a biopsy sample. Direct contact between saliva and the oral cancer makes measurement of salivary metalloproteinase- 9 (MMP-9) an attractive alternative. Material and Methods In total, 30 OSCC patients and 30 healthy controls were included in this prospective study. Saliva samples from both groups were collected, centrifuged and supernatant fluid was subjected to ELISA for assessment of MMP-9. The median salivary MMP-9 values with interquartile range (IQR) of OSCC patients and the…

AdultMaleSalivamedicine.medical_specialtyPathologyMatrix metalloproteinaseGastroenterology03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineBiomarkers TumorCarcinomaHumansMedicineProspective StudiesSalivaProspective cohort studyGeneral DentistryAgedAged 80 and overOral Medicine and PathologyReceiver operating characteristicbusiness.industryResearchCancer030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesMatrix Metalloproteinase 9OtorhinolaryngologySalivary diagnostics030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellFemaleMouth NeoplasmsSurgerybusiness
researchProduct

Reference Values for a Homogeneous Ferritin Assay and Traceability to the 3rd International Recombinant Standard for Ferritin (NIBSC Code 94/572)

1999

Abstract Reference values for two ferritin assays (Tina-quant®a Ferritin, Enzymun®, both Roche Diagnostics, Mannheim, Germany) were established (136 males and 139 females). To rule out inflammation as well as iron deficiency in the reference population, subjects with the C-reactive protein concentration < 5 mg/l, and zinc protoporphyrin < 40 µmol/mol heme and the soluble transferrin receptor < 3 mg/l were selected. Taking into account latent iron deficiency as well as hereditary hemochromatosis the 5–95 percentile range was as follows: male, 27–365 μg/l; female, 13–148 μg/l for Tina-quant®a and 12–151 μg/l for Enzymun®. The Tinaquant® a Ferritin assay showed a very good correlation…

AdultMaleSerial dilutionClinical BiochemistryRoche Diagnosticslaw.inventionImmunoenzyme TechniquesReference ValueslawHumansReference populationbiologyBiochemistry (medical)Reproducibility of ResultsGeneral MedicineMiddle AgedAbbott DiagnosticsMolecular biologyFerritinHomogeneousReference valuesCalibrationFerritinsImmunologybiology.proteinRecombinant DNAFemalecclm
researchProduct

Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren’s syndrome

2014

The diagnosis of primary Sjögren’s syndrome (pSS) is complex, and the saliva test is a potential method to improve the existing diagnostic criteria. Objective: To estimate the diagnostic accuracy of salivary anti-SSA/B antibodies in primary Sjögren’s syndrome (pSS), and to analyze their correlations with clinical and laboratory profiles. Study Design: This study enrolled 100 pSS patients and 140 non-pSS controls, including 40 rheumatoid arthritis (RA) patients, 40 systemic lupus erythematosus (SLE) patients, and 60 healthy controls. Unstimulated whole saliva and stimulated parotid saliva samples were collected from the subjects. Salivary anti-SSA/B antibodies were measured using an enzyme-l…

AdultMalemusculoskeletal diseasesSalivaAnti-nuclear antibodyOdontologíaAutoantigensstomatognathic systemSaliva testingHumansMedicineRheumatoid factorSalivaGeneral DentistryAutoantibodiesOral Medicine and Pathologybusiness.industryResearchAutoantibodyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludeye diseasesstomatognathic diseasesSjogren's SyndromeRibonucleoproteinsOtorhinolaryngologySalivary diagnosticsRheumatoid arthritisImmunologyUNESCO::CIENCIAS MÉDICASFemaleSurgerybusinessAnti-SSA/Ro autoantibodies
researchProduct

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

2010

Background: To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer. Methods: Osteopontin, ALCAM, HER2 and ER mRNA expression in breast cancer tissues of 481 patients were analysed (mRNA microarray analysis, kinetic RT–PCR). Hierarchical clustering was performed in training cohort A (N=100, adjuvant treatment) and validation cohorts B (N=200, no adjuvant treatment, low-risk) and C (N=181, adjuvant treatment, high-risk). Results: Negative/low ER and HER2, high OPN and low ALCAM mRNA expression helped to identify patients at particularly h…

AdultRiskCancer ResearchosteopontinReceptor ErbB-2Eukaryotic Initiation Factor-3discriminative markersBreast NeoplasmsDisease-Free SurvivalHER2 and ER-negative breast cancerBreast cancerActivated-Leukocyte Cell Adhesion MoleculemedicineCluster AnalysisHumansOsteopontinRNA MessengerReceptorskin and connective tissue diseasesMolecular DiagnosticsALCAMALCAMAgedOligonucleotide Array Sequence AnalysisbiologyCell adhesion moleculeDecision TreesActivated-Leukocyte Cell Adhesion MoleculeCancerMiddle Agedmedicine.diseasePrognosisOncologyReceptors EstrogenImmunologybiology.proteinCancer researchFemaleBreast diseaseBritish journal of cancer
researchProduct